Partially Hydrolysed Whey Has Superior Allergy Preventive Capacity Compared to Intact Whey Regardless of Amoxicillin Administration in Brown Norway Rats

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Katrine Bækby Graversen
  • Jeppe Madura Larsen
  • Pedersen, Signe Schultz
  • Laila Vestergaard Sørensen
  • Heidi Frahm Christoffersen
  • Lotte Neergaard Jacobsen
  • Susanne Halken
  • Tine Rask Licht
  • Martin Iain Bahl
  • Katrine Lindholm Bøgh

Background: It remains largely unknown how physicochemical properties of hydrolysed infant formulas influence their allergy preventive capacity, and results from clinical and animal studies comparing the preventive capacity of hydrolysed infant formula with conventional infant formula are inconclusive. Thus, the use of hydrolysed infant formula for allergy prevention in atopy-prone infants is highly debated. Furthermore, knowledge on how gut microbiota influences allergy prevention remains scarce. Objective: To gain knowledge on (1) how physicochemical properties of hydrolysed whey products influence the allergy preventive capacity, (2) whether host microbiota disturbance influences allergy prevention, and (3) to what extent hydrolysed whey products influence gut microbiota composition. Methods: The preventive capacity of four different ad libitum administered whey products was investigated in Brown Norway rats with either a conventional or an amoxicillin-disturbed gut microbiota. The preventive capacity of products was evaluated as the capacity to reduce whey-specific sensitisation and allergic reactions to intact whey after intraperitoneal post-immunisations with intact whey. Additionally, the direct effect of the whey products on the growth of gut bacteria derived from healthy human infant donors was evaluated by in vitro incubation. Results: Two partially hydrolysed whey products with different physicochemical characteristics were found to be superior in preventing whey-specific sensitisation compared to intact and extensively hydrolysed whey products. Daily oral amoxicillin administration, initiated one week prior to intervention with whey products, disturbed the gut microbiota but did not impair the prevention of whey-specific sensitisation. The in vitro incubation of infant faecal samples with whey products indicated that partially hydrolysed whey products might confer a selective advantage to enterococci. Conclusions: Our results support the use of partially hydrolysed whey products for prevention of cow’s milk allergy in atopy-predisposed infants regardless of their microbiota status. However, possible direct effects of partially hydrolysed whey products on gut microbiota composition warrants further investigation.

OriginalsprogEngelsk
Artikelnummer705543
TidsskriftFrontiers in Immunology
Vol/bind12
Antal sider16
ISSN1664-3224
DOI
StatusUdgivet - 2021
Eksternt udgivetJa

Bibliografisk note

Funding Information:
The authors thank Elise Navntoft, Kenneth Rene Worm, Maja Danielsen, Olav Dahlgaard, and Anne ?rngreen for their great assistance with the animal experiments. Furthermore, the authors thank Bodil Madsen, Juliane Margrethe Gregersen, Sarah Grundt Simonsen, Lise Lotte Eriksen, Gesika J?rgensen, and Sofie Emilie Hornslet for their great assistance in the lab. Finally, the authors wish to thank Anny Fr?lund and Camilla Bjerg Kristensen for performing chromatographic analyses, and Anne Blicher for performing the AA analysis. This work was supported by the Danish Dairy Research Foundation and was part of Katrine B?kby Graversen?s PhD Thesis ?Microbiota and Cow?s Milk Allergy?.

Funding Information:
This work was supported by the Danish Dairy Research Foundation.

Publisher Copyright:
© Copyright © 2021 Graversen, Larsen, Pedersen, Sørensen, Christoffersen, Jacobsen, Halken, Licht, Bahl and Bøgh.

ID: 281226375